Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models. Fang DD, Tao R, Wang G, Li Y, et al. BMC Cancer 2022;22:752.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fang DD, Tao R, Wang G, Li Y, et al. Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models. BMC Cancer 2022;22:752.
PMID: 35820889